Last updated at 17 Jul 2024 07:02 AM
Director
DIN: 06610196
Kandru Madhavarao is currently associated with 2 companies as Director. They serve as a Director at CREDO LIFE SCIENCES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06610196.Kandru Madhavarao has previously been associated with 2 companies in roles such as Director, Additional Director and Whole-time director.Kandru Madhavarao is currently involved in 1 different role. Their most recent position is with CREDO PHARMA PRIVATE LIMITED as a Director. The first company Kandru Madhavarao was appointed to as a director was CREDO LIFE SCIENCES PRIVATE LIMITED. Kandru Madhavarao is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Kandru Madhavarao is currently associated with 2 companies as Director. They serve as a Director at CREDO LIFE SCIENCES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06610196.Kandru Madhavarao has previously been associated with 2 companies in roles such as Director, Additional Director and Whole-time director.Kandru Madhavarao is currently involved in 1 different role. Their most recent position is with CREDO PHARMA PRIVATE LIMITED as a Director. The first company Kandru Madhavarao was appointed to as a director was CREDO LIFE SCIENCES PRIVATE LIMITED. Kandru Madhavarao is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (2)
2y 6m 1y 3m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| CREDO LIFE SCIENCES PRIVATE LIMITED | Director | 18-Sep-2015 |
| CREDO PHARMA PRIVATE LIMITED | Director | 05-Oct-2018 |